88.6K
Downloads
199
Episodes
Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines. Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
Episodes
Friday Oct 04, 2024
The pink-haired CEO
Friday Oct 04, 2024
Friday Oct 04, 2024
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Emma Banks, CEO at ramarketing.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Emma Banks, CEO at ramarketing, covering:
- How a conversation with her late father led Emma to look out for herself and jump into the unknown
- The contrast of two different CEO roles - stepping from a hand-to-mouth cash-strapped tech business into a rapid-growth business
- Why Emma decided to do the UNTHINKABLE...and work with Raman to run ramarketing
- The one piece of advice that has helped Emma navigate being a CEO under PE ownership
- And why, despite some challenges on the horizon...the only way is up for the pharma services space
Having spent over 20 years of experience in the industry with a focus on clinical research and a former board member of the Society of Clinical Data Management (SCDM), Emma is a seasoned expert in the global pharmaceutical and life sciences contract services sector.
After earning a PhD in Immunology and two years of postdoctoral research, Emma led the data management team at a small biometrics CRO before going on to run an international life sciences software business.
Today, Emma heads up ramarketing, overseeing growth plans across North America and Europe, ensuring exceptional service to clients looking to grow in life sciences.
This episode of Molecule to Market is sponsored by Vetter, a global leader in aseptic filling solutions for injectable products in the pharmaceutical and biotech industries. Discover more about Vetter’s comprehensive services, from early-stage development to commercial production, and how they support clients in delivering high-quality therapies to the market.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.